𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesis

✍ Scribed by Eitan Yefenof; Yaacob Ben-David

Book ID
113238761
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
450 KB
Volume
10
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Radiation leukemia virus (RadLV)-induced
Radiation leukemia virus (RadLV)-induced leukemogenesis is associated with an increased number and activity of thymic macrophages
✍ E. Messika; R. Gallily; E. Yefenof πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 896 KB

The radiation leukemia virus (RadLV) is a chronic leukemia retrovirus that induces thymic lymphomas in C57BU6 mice after a latency of 3 to 6 months. During the pre-leukemic (PL) period, the number of thymic macrophages gradually increased up to 100 fold. Of the cells in a RadLV-induced lymphoma, 0.3

High- and low-leukemogenic variants of t
High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppression
✍ Eitan Yefenof; David Zilcha πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 French βš– 494 KB

## Abstract Adult C57BL/6 mice inoculated intrathymically (i.t.) with the highly leukemogenic variant of the radiation leukemia virus (A‐RadLV) develop suppressor cells capable of specifically abrogating a potential anti‐tumor cytotoxic response __in vitro__. Suppressor cells were generated directl

High- and low-leukemogenic variants of t
High- and low-leukemogenic variants of the radiation leukemia virus (RadLV): Immunogenic, suppressive and genetic properties in relation to leukemogenic activity
✍ Eitan Yefenof; Ya'acob Ben David; Moshe Kotler πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 819 KB

C57BL/6 (B6) mice inoculated with the highly leukemogenic variant of the radiation leukemia virus (A-RadLV) develop suppressor cells capable of abrogating potential anti-tumor immunity in vitro and in vivo. Inoculation of B6 animals with the low-leukemogenic D-RadLV variant does not result in suppre